All Medicines and Healthcare Products Regulatory Agency articles – Page 2
See all articles with this subject.
-
NewsTrust postpones trials after regulator partially suspends licence
A trust has been unable to start some new cancer trials as planned after regulators partially suspended its licence to manufacture medicines.
-
News
Higher safety hurdle needed for health apps – Hancock
Regulators need to demand more evidence that health apps are safe for use in the NHS, the health and social care secretary has said
-
News
CQC to inspect triage app use
The Care Quality Commission will inspect the safe use of triage apps in the NHS after receiving legal advice.
-
News
Training needed to stop patient risk from AI and robots - review
The NHS needs to drastically boost its ability to asses new digital technologies, such as artificial intelligence and genomics, or risk entrenching health inequities and harming patients, according to a government review.
-
News
New pharma deal raises cap on drugs' spending
The government has negotiated a new deal with the pharmaceutical industry which raises the NHS’ cap on spending on branded medicines.
-
News
CEO of UK medicines' regulator to step down
The chief executive of the UK’s medicine regulator is to leave his post in September 2019, six months after the UK is due to leave the European Union.
-
News
Brexit: Ministers launch 'tens of millions' bid to stockpile medicine
Ministers have launched a tender worth “tens of millions” of pounds to provide extra storage capacity in the event of the UK crashing out of the EU without a deal.
-
News
Exclusive: No-deal Brexit 'will force up price of generic drugs'
The price of generic drugs could be forced up in the case of a no-deal Brexit, HSJ understands from senior industry sources.
-
News
Minister pledges to strengthen tech safety code
The government is intending to introduce a new regulatory regime for health digital technology, amid concerns the current system is confusing and fragmented.
-
News
Pharma says government must act quickly to safeguard generic drugs supply
Pharmaceutical industry leaders have warned the government needs to be “fleet of foot” to avoid a significant cost if a no-deal Brexit disrupts approval of generic and biosimilar medicines.
-
Expert Briefing
The Integrator: How quickly is general practice reforming?
What NHS England isn’t telling you, and more indispensable insight for commissioners. This week by HSJ primary care and community services correspondent Rebecca Thomas.
-
Expert Briefing
The Integrator: "Loaded gun" medicine plans may richochet back onto government
What NHS England isn’t telling you, and more indispensable insight for commissioners. This week by HSJ commissioning correspondent Sharon Brennan
-
News
Ministers to ask drug companies to stockpile six weeks of medication
Drug companies are due to be asked to stockpile up to six weeks of medications ahead of a potential no deal Brexit, HSJ understands.
-
News
Brexit stockpiling will face 'serious issues' and huge costs
s 3There are likely to be “serious issues” with the government’s plan to stockpile drugs and medical devices in case of a no-deal Brexit, according to senior figures in the pharmaceutical industry.
-
News
Better evidence needed before deploying digital medicine - review lead
A major review of new technologies and workforce in the NHS will “come down hard” in favour of stronger evidence before new digital treatments are rolled out, the lead reviewer told HSJ .
-
News
Medical apps to face new scrutiny, amid criticism of "fragmentation"
The rapid growth in medical apps will come under stricter regulatory scrutiny amid criticism that the current system is “fragmented”.
-
News
Lord Darzi appointed chair of new innovation panel
Former health minister Lord Darzi has been appointed chair of a new innovation panel which will choose which “transformative” medical products should be fast tracked into the NHS.
-
News
Safety regulators reviewing concerns about Babylon's 'chatbot'
Safety regulators are reviewing concerns raised about Babylon Healthcare’s symptom checker “chatbot” following multiple complaints, HSJ has learned.
-
News
NHS hit by seven-fold increase in bill for certain drugs
NHS commissioners were hit by a seven-fold increase in the bill for certain generic drugs in 2017-18, after some medicines were subject to massive price hikes.
-
HSJ Local
Four trusts looking into pharmacy joint venture
Trusts in Berkshire and Surrey are looking at creating a pharmacy joint venture modelled on their existing pathology service.
- Previous Page
- Page1
- Page2
- Page3
- Next Page